FDA Drug Application (207533) for ARISTADA by ALKERMES INC

Back to FDA Applications sponsored by ALKERMES INC

Application Number207533
Product Number001
FormSUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage441MG/1.6ML (275.63MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameARISTADA
Active IngredientARIPIPRAZOLE LAUROXIL



Back to FDA Applications sponsored by ALKERMES INC